Literature DB >> 34006841

CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph.

Luca Hensen1, Patricia T Illing2, E Bridie Clemens1, Thi H O Nguyen1, Marios Koutsakos1, Carolien E van de Sandt1,3, Nicole A Mifsud2, Andrea T Nguyen2, Christopher Szeto2, Brendon Y Chua1, Hanim Halim2, Simone Rizzetto4, Fabio Luciani4, Liyen Loh1, Emma J Grant1,2, Phillipa M Saunders1, Andrew G Brooks1, Steve Rockman1,5, Tom C Kotsimbos6,7, Allen C Cheng8,9, Michael Richards10, Glen P Westall11, Linda M Wakim1, Thomas Loudovaris12, Stuart I Mannering12, Michael Elliott13,14, Stuart G Tangye15,16, David C Jackson1, Katie L Flanagan17,18,19,20, Jamie Rossjohn2,21,22, Stephanie Gras2,22,23, Jane Davies24, Adrian Miller25, Steven Y C Tong10,24, Anthony W Purcell2, Katherine Kedzierska26.   

Abstract

Indigenous people worldwide are at high risk of developing severe influenza disease. HLA-A*24:02 allele, highly prevalent in Indigenous populations, is associated with influenza-induced mortality, although the basis for this association is unclear. Here, we define CD8+ T-cell immune landscapes against influenza A (IAV) and B (IBV) viruses in HLA-A*24:02-expressing Indigenous and non-Indigenous individuals, human tissues, influenza-infected patients and HLA-A*24:02-transgenic mice. We identify immunodominant protective CD8+ T-cell epitopes, one towards IAV and six towards IBV, with A24/PB2550-558-specific CD8+ T cells being cross-reactive between IAV and IBV. Memory CD8+ T cells towards these specificities are present in blood (CD27+CD45RA- phenotype) and tissues (CD103+CD69+ phenotype) of healthy individuals, and effector CD27-CD45RA-PD-1+CD38+CD8+ T cells in IAV/IBV patients. Our data show influenza-specific CD8+ T-cell responses in Indigenous Australians, and advocate for T-cell-mediated vaccines that target and boost the breadth of IAV/IBV-specific CD8+ T cells to protect high-risk HLA-A*24:02-expressing Indigenous and non-Indigenous populations from severe influenza disease.

Entities:  

Year:  2021        PMID: 34006841     DOI: 10.1038/s41467-021-23212-x

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  59 in total

1.  Pandemic influenza A (H1N1) 2009: risk factors for hospitalization.

Authors:  Luana Lenzi; Ângela Maron de Mello; Lineu Roberto da Silva; Mônica Holtz Cavichiolo Grochocki; Roberto Pontarolo
Journal:  J Bras Pneumol       Date:  2012 Jan-Feb       Impact factor: 2.624

Review 2.  Emerging influenza viruses and the prospect of a universal influenza virus vaccine.

Authors:  Florian Krammer
Journal:  Biotechnol J       Date:  2015-03-02       Impact factor: 4.677

3.  Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia's Northern Territory.

Authors:  Shaun M Flint; Joshua S Davis; Jiunn-Yih Su; Erin P Oliver-Landry; Benjamin A Rogers; Aaron Goldstein; Jane H Thomas; Uma Parameswaran; Colin Bigham; Kevin Freeman; Paul Goldrick; Steven Y C Tong
Journal:  Med J Aust       Date:  2010-05-17       Impact factor: 7.738

4.  Australian vaccine preventable disease epidemiological review series: Influenza 2006 to 2015.

Authors:  Jean Li-Kim-Moy; Jiehui Kevin Yin; Cyra Patel; Frank H Beard; Clayton Chiu; Kristine K Macartney; Peter B McIntyre
Journal:  Commun Dis Intell Q Rep       Date:  2016-12-24

5.  Cellular immune correlates of protection against symptomatic pandemic influenza.

Authors:  Saranya Sridhar; Shaima Begom; Alison Bermingham; Katja Hoschler; Walt Adamson; William Carman; Thomas Bean; Wendy Barclay; Jonathan J Deeks; Ajit Lalvani
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440

6.  Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities.

Authors:  Sergio Quiñones-Parra; Emma Grant; Liyen Loh; Thi H O Nguyen; Kristy-Anne Campbell; Steven Y C Tong; Adrian Miller; Peter C Doherty; Dhanasekaran Vijaykrishna; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-06       Impact factor: 11.205

7.  Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.

Authors:  J H C M Kreijtz; G de Mutsert; C A van Baalen; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

8.  Cytotoxic T-cell immunity to influenza.

Authors:  A J McMichael; F M Gotch; G R Noble; P A Beare
Journal:  N Engl J Med       Date:  1983-07-07       Impact factor: 91.245

9.  Hospitalizations for pandemic (H1N1) 2009 among Maori and Pacific Islanders, New Zealand.

Authors:  Ayesha Verrall; Katherine Norton; Serena Rooker; Stephen Dee; Leeanne Olsen; Chor Ee Tan; Sharon Paull; Richard Allen; Timothy K Blackmore
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

Review 10.  Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic.

Authors:  Rafi Ahmed; Michael B A Oldstone; Peter Palese
Journal:  Nat Immunol       Date:  2007-11       Impact factor: 25.606

View more
  7 in total

Review 1.  T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles.

Authors:  Luca Hensen; Patricia T Illing; Louise C Rowntree; Jane Davies; Adrian Miller; Steven Y C Tong; Jennifer R Habel; Carolien E van de Sandt; Katie L Flanagan; Anthony W Purcell; Katherine Kedzierska; E Bridie Clemens
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

2.  SARS-CoV-2-specific CD8+ T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph.

Authors:  Louise C Rowntree; Jan Petersen; Jennifer A Juno; Priyanka Chaurasia; Kathleen Wragg; Marios Koutsakos; Luca Hensen; Adam K Wheatley; Stephen J Kent; Jamie Rossjohn; Katherine Kedzierska; Thi Ho Nguyen
Journal:  Immunol Cell Biol       Date:  2021-06-30       Impact factor: 5.853

3.  HLA-A*11:01-restricted CD8+ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous people.

Authors:  Jennifer R Habel; Andrea T Nguyen; Louise C Rowntree; Christopher Szeto; Nicole A Mifsud; E Bridie Clemens; Liyen Loh; Weisan Chen; Steve Rockman; Jane Nelson; Jane Davies; Adrian Miller; Steven Y C Tong; Jamie Rossjohn; Stephanie Gras; Anthony W Purcell; Luca Hensen; Katherine Kedzierska; Patricia T Illing
Journal:  PLoS Pathog       Date:  2022-03-07       Impact factor: 6.823

4.  Protocol for generation of human peptide-specific primary CD8+ T cell lines.

Authors:  Emma J Grant; Stephanie Gras
Journal:  STAR Protoc       Date:  2022-07-31

5.  Indigenous peoples and pandemics.

Authors:  Daniele E Alves; Svenn-Erik Mamelund; Jessica Dimka; Lone Simonsen; Mathias Mølbak; Søren Ørskov; Lisa Sattenspiel; Lianne Tripp; Andrew Noymer; Gerardo Chowell-Puente; Sushma Dahal; Taylor P Van Doren; Amanda Wissler; Courtney Heffernan; Kirsty Renfree Short; Heather Battles; Michael G Baker
Journal:  Scand J Public Health       Date:  2022-05-12       Impact factor: 3.199

6.  Strategies targeting hemagglutinin cocktail as a potential universal influenza vaccine.

Authors:  Xuejie Liu; Tianyi Zhao; Liangliang Wang; Minchao Li; Caijun Sun; Yuelong Shu
Journal:  Front Microbiol       Date:  2022-09-29       Impact factor: 6.064

Review 7.  The pockets guide to HLA class I molecules.

Authors:  Andrea T Nguyen; Christopher Szeto; Stephanie Gras
Journal:  Biochem Soc Trans       Date:  2021-11-01       Impact factor: 5.407

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.